embryonic human stem cells Archivi - World Congress for Freedom of scientific research

By James Maynard The first genetic modifications of human embryos by researchers in China have left scientists and the global public divided over ethics. People around the world are grouping into several camps over the scientific breakthrough, which has added fuel to the already heated debate. Genetic editing of humans while they develop in the

The Food and Drug Administration (FDA) approves a clinical trial using stem cell therapy on patients with spinal cord injury. The California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, is funding the trial. The Phase 1/2a clinical trial is designed to test the safety of this approach and to see if it has any

The California Institute for Regenerative Medicine (CIRM), a state agency with a US$3-billion budget for stem-cell research, is in need of more funding. Nature reports that “CIRM had to revamp its structure and practices in response to complaints about inefficiency and potential conflicts of interest. It has also had to adapt its mission to seismic